![MarineLab Profile](https://pbs.twimg.com/profile_images/1070757575048785920/LJh4PXKd_x96.jpg)
MarineLab
@lab_marine
Followers
2K
Following
3K
Statuses
696
Joined February 2016
RT @vib_ccb: 🚨 Job alert🚨 VIB Science Policy is looking for a European Health Cancer Project Officer to support the role of VIB in groundbr…
0
2
0
@Yael_David__ @vib_ccb @LambrechtsDlab @FendtLab @FuksLab Meant to say/write ..we cannot wait! Cheers
0
0
1
🚀 Exciting Opportunity! We're on the lookout for passionate young cancer biologists ready to take the lead in their own research group! Join us in a highly supportive environment and enjoy a competitive starting package. Let's make a difference together! 🌟 #CancerResearch
🚨 Job alert 🚨 We are #hiring a #groupleader in functional cancer #Genomics 👉 More information & applications:
1
12
34
@daniela_oaks @Ludwig_Cancer @SocietyMelanoma A truly inspiring leader in the field …bravo, Colin!!!
0
0
5
RT @daniela_oaks: Colin Goding @Ludwig_Cancer gets the Lifetime Research Award! Colin has done groundbreaking work on MITF and phenotype sw…
0
3
0
@melanomateam @nyulangone @locusbearico @SocietyMelanoma indeed...Nice work!! Keep up with the good work, Pietro!!
0
0
2
Very much looking forward to this meeting as well!! Do join us for what promises to be a fantastic meeting!
@lab_marine we're looking forward to your presentation at #AMC25 in the Dominican Republic🇩🇴 next February! Please RT to let your followers know Talk Submission closes next week! ✅Register & Submit:
0
1
12
RT @NatureRevCancer: NEW content online! Cancer drug-tolerant persister cells: from biological questions to clinical opportunities https://…
0
62
0
A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to @BardelliLab for taking the lead.
Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters:Â
0
3
16